 |
|
| ADVANCES IN ENZYME REGULATION
| |
| | |
|
|
Editors:
George Weber
See editorial board for all editors information
Description
This internationally acclaimed series reports progress at the cutting edge in the strategic area of regulation
at the molecular level. In an integrated presentation of original papers, leading scientists, Nobel Prize winners and other outstanding
experts from many countries review the best research produced each year and evaluate what is newest and what promises to be the most
important in clinical and basic investigations. The volumes serve as guideposts and beacons for investigators in planning research and
teaching students in basic and clinical fields of endeavour. These books advance the general front of studies on metabolic regulation
and the understanding of the molecular biology of control of gene expression by hormones, drugs and growth factors in cancer cells and
in clinical situations of diabetes, inborn errors of metabolism and neoplasia.
Review of Volume 33: "Careful consideration
and planning have been invested in the crafting of this volume, and George Weber may feel well satisfied with the final result ......
the book succeeds in its aim to be a source of information and inspiration, and a laboratory and teaching companion.", Clinical Oncology
Bibliographic & ordering information
ISSN: 0065-2571
Imprint: PERGAMON
Commenced publication 1963
Subscriptions for the year 2009,
Volume 49,
1 issue
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Personal price: Order form
USD 162 for all countries except Europe, Japan and Iran
JPY 18,600 for Japan
EUR 121 for European countries and Iran
Institutional price: Order form
EUR 1,051 for European countries and Iran
JPY 139,500 for Japan
USD 1,175 for all countries except Europe, Japan and Iran
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Audience
Basic scientists and clinicians interested in metabolic regulation, chemotherapy resistance, enzymic targeting and the role of oncogenes.
Impact factor of this journal
2005: 1.587
© Journal Citation Reports 2006, published by Thomson Reuters
602/177
Last update: 28 Aug 2008
|
|
| |
| | |
|
|
| |
